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Roles of the inesangium in glomerular function. Among the multiple
functions of the mesangial cell in glomerular physiology and pathophysi-
ology, those of structural support of the capillary network, of participation
in filtration regulation and in glomerular injury have attracted consider-
able interest. These roles are supported by studies with anti-Thy 1.1
antibody induced mesangiolysis in rats and by genetic knockout experi-
ments of PDGF or PDGF-receptors in mice. These mice show a lack of
mesangial cell development and a concomitant failure to establish a
glomerular capillary network. Micropuncture experiments in the rats with
mesangiolysis also provide support for a role of mesangial cells in the
regulation of glomerular filtation. Numerous studies have established a
contribution of mesangial cells to immunological and non-immunological
injury in the glomerulus. Under many conditions this involves the recruit-
ment and activation of macrophages, which require generation of chemo-
tactic peptides and expression of adhesion molecules. Stimulation of
mesangial cells with immune complexes and proinflammatory cytokines
such as TNF-a or IL-i results in the release of chemokines and in the
appearance of adhesion molecules on the mesangial cells. The generation
of reactive oxygen species appears to play a major role in this context and
involves, at least in part, the activation of the transcription factor NF-KB.
These results point toward mesangial cells as important participants in
glomerular injury.
Homer Smith dealt only briefly with the mesangium in his text
The Kidney [1]. He assigned it a potential role in the anatomical
structure of the glomerulus without discussing its potential con-
tribution to the regulation of glomerular function very much. On
the other hand, he had the foresight of mentioning that mesangial
cells could be of significance in immune-mediated glomerulone-
phritis as mesangial cell proliferation was frequently observed in
glomerulonephritis. In the meantime, our understanding of mes-
angial cell anatomy and function has evolved considerably thanks
to improved techniques such as immunohistochemistry, electron
microscopy, cell culture, molecular biology and additional exper-
imental models of glomerular disease and organ development
[2—7]. Therefore, a list of the potential roles of mesangial cells
would at present include:
1. Structural support for the glomerulus, and specifically the
capillary loops.
2. Generation and turnover of extracellular mesangial matrix.
3. Target site for vasoactive agents such as: (a) vasoconstrictors,
such as angiotensin II, endothelin, vasopressin, and norepineph-
rine; (b) vasodilators, such as atriopeptin, nitric oxide, prostaglan-
dins PGE2 and PGI2, and dopamine.
4. Target site for inflammatory mediators, growth factors, and
cytokines with effects on, for example, local hemodynamics, cell
proliferation and matrix turnover.
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5. Site of production of vasoactive mediators and growth
modifying agents, such as prostaglandins, thromboxane, lipoxy-
genase products, platelet activating factor (PAP), nitric oxide, etc.
6. Site of production of various growth factors and cytokines
such as PDGF, IL-i, CSF-1, TGF-f3, etc.
7. Expression of chemokines and adhesion molecules.
8. Generation of plasminogen activator and inhibitors.
9. Handling of macromolecules such as lipids, immune com-
plexes and advanced glycation endproducts (AGE).
This list is by no means complete, and many of the various
aspects of mesangial cell biology have been reviewed [2, 3, 5, 6].
This paper comments briefly on the contribution of the mesangial
cell to structural support and functional modification of the
glomerulus and to its role during glomerular injury.
Role of mesangial cells for the structural and functional
integrity of the glomerulus
The mesangium is essential for the glomerular capillary network
The potential of the mesangial cell in providing support for the
glomerular capillary loops had been inferred from elegant ultra-
structural studies [8]. Recently, an immunological model of
mesangiolysis and genetic in vivo knock-outs for PDGF or PDGF
receptors have provided direct evidence that mesangial cells are
necessary for the generation and maintenance of glomerular
capillary loops [4, 9—11].
The immunological model takes advantage of the unique
presence of the Thy 1.1 antigen on mesangial cell membranes in
rats. Thus injection of anti-Thy-1.1 antibodies results in a com-
plement-dependent lysis of mesangial cells with loss of individual
capillaries. Instead, one observes the formation of intercommu-
nicating vascular microaneurysmal sacs. Upon the regrowth of
mesangial cells, probably starting from the glomerular vascular
pole, the individual capillaries are re-established [10, 11].
Further support for the significance of mesangial cells in
establishing individual glomerular capillary loops comes from
genetically modified mice. In both mice made either deficient in
PDGF-!3 or in PDGF-J3 receptor through mutagenesis, there is a
failure of mesangial cells to grow into the glomerulus during renal
development [4, 9]. Glomerular capillary basement membranes
appear to develop normally as do glomerular podocytes and
endothelial cells. The lack of mesangial cells results in the
formation of intraglomerular vascular sacs, instead of the normal
capillary network [4, 9]. These observations in the PDGF- and
PDGF-receptor knock-out mice clearly establish (among others)
the importance of PDGF for mesangial cell growth, that had been
suspected based on mesangial cell culture and in vivo experimen-
tal models such as the anti-Thy 1.1 nephritis and human biopsies
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[7]. Furthermore, these experiments show that mesangial cells are
a sine qua non for the establishment and maintenance of glomer-
ular capillary tufts.
Mesangium may modify glomerular filtration
The model of anti-Thyl.1 induced mesangiolysis also to some
extent allows the evaluation of the potential role of mesangial
cells in the local modification of glomerular filtration. Based on
the in vitro observations of contractility of isolated glomeruli and
cultured mesangial cells in response to vasoactive agents [2, 3],
and in analogy to the regulation of intraglomerular blood flow in
amphibians [12], it has been proposed that mesangial cells would
not only provide a counter force to changes in intraglomerular
capillary pressure, but could also influence blood flow through
individual capillary loops and could thus modify the effective
capillary filtration area [2, 3]. When glomerular blood flow and
filtration were examined during the phase of mesangiolysis in the
anti-Thy 1.1 model, no difference in the autoregulation of glomer-
ular blood flow was observed [10, 11]. In contrast, autoregulation
of GFR and the glomerular ultrafiltration coefficient were re-
duced in the rats with mesangiolysis, indicating of a contribution
of mesangial cells to the intraglomerular modification of filtration
[10, 11]. Under physiological conditions the influence of vasoac-
tive agents to change the tone of mesangial cells could redistribute
intraglomerular blood flow, resulting in increased flow through
some and decreased flow through other capillaries. The capillaries
with decreased flow could reach filtration equilibrium [13], which
would translate into a decrease in effective filtration surface and
hence in ultrafiltration coefficient. Such alterations in blood flow
through individual glomerular capillary loops had been observed
in the initial micropuncture studies by Richards and Schmidt in
the frog over 50 years ago [12] and have been noted by video
recordings in rat kidneys by Steinhausen, Endlich and Wiegman
[141. In this manner the glomerular mesangial cell may not only
contribute to a fine-tuning of SNGFR under physiological condi-
tions, but may also mediate part of the changes in GFR observed
in a number of experimetal renal diseases [3, 61.
Role of mesangial cells in glomerular injury
Binding and uptake of macromolecules influence mesangial cells
"Clearance" of macromolecules by mesangial cells would have
been a novel concept for Homer Smith. Yet, it has become
apparent that the mesangium is exposed to a variety of macro-
molecules because of the fenestrated glomerular capillary endo-
thelium and the lack of basal membrane intervening between
capillary lumen and mesangium [8]. Thus macromolecules that
may percolate through the mesangium include various experimen-
tally-injected indicator substances, circulating lipoproteins (VLDL,
LDL, HDL etc.), proteins modified by advanced gylcation (AGE)
and immune complexes [3, 15, 16]. Depending on their size,
concentration, charge, affinity for either matrix components or
surface receptors on mesangial cells, these macromolecules leave
the mesangium towards the glomerular pole via mesangial chan-
nels, are taken up by mesangial cells, or remain trapped in the
mesangial matrix [3]. These processes can also be modified by
vasoactive agents [17]. Receptor-mediated uptake of such macro-
molecules by mesangial cells has been demonstrated for lipopro-
teins, advanced glycated proteins and IgG and IgA complexes [15,
16, 18, 19]. Depending on the potential modification of these
macromolecules and on their concentration the receptor-medi-
ated endocystis may result in either their clearance, that is,
degradation by mesangial cells without untoward consequences,
or in activation of the cells leading to glomerular inflammation-
injury. As an example I shall discuss the effects of Fc-receptor
mediated uptake of IgG complexes by mesangial cells.
IgG complexes induce the generation of chemokines and adhesion
molecules by mesangial cells
Leukocyte infiltration is a hallmark of immune-mediated gb-
merulonephritis [20]. The recruitment of leukocytes to the site of
injury requires at least the local release of leukocyte chemotactic
and activating factors [21], and the expression of adhesion mole-
cules [22] on both infiltrating leukocytes and the local cells such
as glomerular endothelial and mesangial cells in our case. We and
others have demonstrated that mesangial cells can express specify
receptors for IgG complexes [19] and that their occupancy results
in the release of mediators of inflammation, including reactive
oxygen species [23]. We then evaluated the possibility that IgG
complexes could induce the production of the chemokines mono-
cyte-chemoattractant peptide-1 (MCP-1) and RANTES and the
adhesion molecule ICAM-1 in mesangial cells, as MCP-1 and
RANTES are important for macrophage recruitment and ICAM-1
for their local adhesion. Furthermore, we considered the possi-
bility that reactive oxygen species may be involved in this process.
Our results show in fact that IgG complexes induce expression of
MCP-1, RANTES and ICAM-1 in mesangial cells [24, 25]. On
one hand this process could be decreased by coadministration of
scavengers for free radicals, while on the other hand generation of
superoxide anion by a system of xanthine oxidase plus hypoxan-
thine stimulated the expression of MCP-1, RANTES and ICAM-1
[23]. These data support a role for free radicals as intermediates
in the observed gene induction. Finally, we could demonstrate
that these changes in gene expression occurred in paralel with the
respective avivation or inhibition of the transcription factor
NF-KB [26]. NF-KB is involved in transciptional regulation of
MCP-1, RANTES and ICAM-1 [27]. These results support the
postulate that reactive oxygen species may play an important role
as intermediate messengers in the activation of the transcription
factor NE-KB and the resulting expression. This hypothesis could
help to explain the almost uniform accumulation of macrophages
to sites of injury-irrespective of the etiology of the initiating
process, as production of free radicals is a common feature of
tissue injury. The significance of these in vitro observations with
cultured mesangial cells for in vivo immune-mediated glomerular
injury is supported by data that show expression of, for example,
MCP-1, RANTES and ICAM-1 in experimental glomerular dis-
eases and in biopsies of patients with immune-complex glomeru-
lonephritis [28]. Therefore, Homer Smith's prescient remark that
mesangial cells may play a role in glomerulonephritis has stood
the test of time.
Reprint requests to Prof Dr. D. Schlondo,jf Medical Policlinic,
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